ACA
ANAC

Apis Capital Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Apis Capital Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.71M Buy
+23,000
New +$3M 3.75% 12

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM

Apis Capital Advisors's ANAC Position: Q3 2015 in Review

Apis Capital Advisors opened a new position in ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2015: 23,000 shares worth $2.71M. The stake represents 3.75% of the portfolio and ranks #12 among its holdings.

213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.

  • Apis Capital Advisors held 23,000 shares of ANACOR PHARMACEUTICALS INC COM worth $2.71M as of Q3 2015.
  • ANACOR PHARMACEUTICALS INC COM was a new Apis Capital Advisors position in Q3 2015.
  • ANACOR PHARMACEUTICALS INC COM made up 3.75% of Apis Capital Advisors's portfolio in Q3 2015, its #12 holding.
  • 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.

Based on Apis Capital Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.